FDA Inspection 633391 — New York Blood Center Inc

New York Blood Center Inc — FEI 2170665

The FDA completed an inspection of New York Blood Center Inc on Dec 4, 2009 in St. Paul, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 4, 2009
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
St. Paul, MN (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.